Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus
- PMID: 34177788
- PMCID: PMC8219973
- DOI: 10.3389/fneur.2021.686398
Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus
Abstract
Migraine is a disabling neurovascular disorder, characterized by moderate to severe unilateral headaches, nausea, photophobia, and/or phonophobia, with a higher prevalence in women than in men, which can drastically affect the quality of life of migraine patients. In addition, this chronic disorder is related with metabolic comorbidities associated with the patient's lifestyle, including obesity and diabetes mellitus (DM). Beyond the personal and socioeconomic impact caused by migraine, obesity and DM, it has been suggested that these metabolic disorders seem to be related to migraine since: (i) they are a risk factor for developing cardiovascular disorders or chronic diseases; (ii) they can be influenced by genetic and environmental risk factors; and (iii) while clinical and epidemiological studies suggest that obesity is a risk factor for migraine, DM (i.e., type 1 and type 2 DM) have been reported to be either a protective or a risk factor in migraine. On this basis, and given the high worldwide prevalence of migraine, obesity, and DM, this article provides a narrative review of the current literature related to the association between the etiology and pathophysiology of migraine and these metabolic disorders, considering lifestyle aspects, as well as the possible involvement of neurotransmitters, neuropeptides, and/or sex hormones. While a link between migraine and metabolic disorders has been suggested, many studies are contradictory and the mechanisms involved in this association are not yet sufficiently established. Therefore, further research should be focused on understanding the possible mechanisms involved.
Keywords: CGRP; comorbidities; diabetes mellitus; lifestyle; metabolic disorders; migraine; obesity.
Copyright © 2021 Rivera-Mancilla, Al-Hassany, Villalón and MaassenVanDenBrink.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Influence of metabolic state and body composition on the action of pharmacological treatment of migraine.J Headache Pain. 2024 Feb 13;25(1):20. doi: 10.1186/s10194-024-01724-3. J Headache Pain. 2024. PMID: 38347465 Free PMC article. Review.
-
[Metabolic syndrome and prevention of migraine headache].Brain Nerve. 2009 Oct;61(10):1143-53. Brain Nerve. 2009. PMID: 19882941 Review. Japanese.
-
Basic mechanisms of migraine and its acute treatment.Pharmacol Ther. 2012 Dec;136(3):319-33. doi: 10.1016/j.pharmthera.2012.08.011. Epub 2012 Aug 24. Pharmacol Ther. 2012. PMID: 22939884
-
Obesity, migraine, and chronic migraine: possible mechanisms of interaction.Neurology. 2007 May 22;68(21):1851-61. doi: 10.1212/01.wnl.0000262045.11646.b1. Neurology. 2007. PMID: 17515549 Review.
-
The Development and Impact of Anxiety With Migraines: A Narrative Review.Cureus. 2022 Jun 29;14(6):e26419. doi: 10.7759/cureus.26419. eCollection 2022 Jun. Cureus. 2022. PMID: 35923673 Free PMC article. Review.
Cited by
-
A Digital Health Application Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Proof-of-Concept Data from a Retrospective Cohort Study.J Clin Med. 2022 Feb 20;11(4):1117. doi: 10.3390/jcm11041117. J Clin Med. 2022. PMID: 35207390 Free PMC article.
-
Applying a biopsychosocial model to migraine: rationale and clinical implications.J Headache Pain. 2022 Aug 11;23(1):100. doi: 10.1186/s10194-022-01471-3. J Headache Pain. 2022. PMID: 35953769 Free PMC article. Review.
-
A role of NLRP3 and MMP9 in migraine progression: a systematic review of translational study.Front Neurol. 2024 May 21;15:1307319. doi: 10.3389/fneur.2024.1307319. eCollection 2024. Front Neurol. 2024. PMID: 38836002 Free PMC article.
-
Epidemiology of clinically significant migraine in Israel: a retrospective database study.J Headache Pain. 2025 Feb 3;26(1):24. doi: 10.1186/s10194-025-01961-0. J Headache Pain. 2025. PMID: 39901126 Free PMC article.
-
Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China.Pain Ther. 2023 Jun;12(3):751-769. doi: 10.1007/s40122-023-00494-1. Epub 2023 Mar 22. Pain Ther. 2023. PMID: 36944864 Free PMC article.
References
-
- Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, et al. . Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. (2013) 53:1278–99. 10.1111/head.12150 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials